Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 200M | 206M | 213M | 196M | 213M | 212M |
| Cost of revenue | 63M | 62M | 61M | 62M | 64M | 64M |
| Gross profit | 138M | 144M | 152M | 134M | 150M | 147M |
| Research and development | 27M | 28M | 26M | 28M | 29M | 27M |
| Selling, general and administrative | 62M | 68M | 67M | 67M | 69M | 72M |
| Operating expenses | 168M | 167M | 481M | 163M | 170M | 184M |
| Operating income | −31M | −23M | −329M | −29M | −20M | −37M |
| Pre-tax income | −34M | −26M | −331M | −29M | −21M | −37M |
| Income tax | 0 | 1M | −100,000 | −29M | 900,000 | −500,000 |
| Net income | −34M | −27M | −331M | −100,000 | −22M | −37M |
| Earnings per share | −0.36 | −0.29 | −3.57 | 0.00 | −0.24 | −0.41 |
| Earnings per share, diluted | −0.36 | −0.29 | −3.57 | 0.00 | −0.24 | −0.41 |
| Weighted average shares | 94M | 93M | 93M | 91M | 91M | 91M |
| Weighted average shares, diluted | 94M | 93M | 93M | 91M | 91M | 91M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 124M | 150M | 145M | 74M | 92M | 102M | 100M | 92M |
| Short-term investments | — | — | — | — | — | 0 | 0 | 5M |
| Receivables | 124M | 115M | 118M | 137M | 120M | 121M | 126M | 118M |
| Inventory | 28M | 31M | 32M | 29M | 28M | 28M | 26M | 26M |
| Current assets | 313M | 333M | 345M | 284M | 287M | 298M | 293M | 292M |
| Property, plant and equipment | 112M | 114M | 111M | 113M | 114M | 117M | 115M | 116M |
| Goodwill | 47M | 52M | 52M | 52M | 286M | 286M | 286M | 286M |
| Total assets | 674M | 707M | 728M | 677M | 1.01B | 1.03B | 1.08B | 1.09B |
| Current liabilities | 130M | 134M | 148M | 200M | 151M | 164M | 154M | 149M |
| Short-term debt | — | — | — | 59M | — | 0 | — | — |
| Long-term debt | 120M | 120M | 120M | 0 | 59M | 40M | 39M | 39M |
| Total liabilities | 336M | 339M | 355M | 289M | 301M | 327M | 350M | 345M |
| Equity | 337M | 368M | 373M | 388M | 705M | 701M | 732M | 741M |
| Shares outstanding | 94M | 94M | 93M | 93M | 92M | 91M | 91M | 91M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −16M | — | — | −16M | — | — |
| Depreciation and amortisation | 13M | — | — | 14M | — | — |
| Share-based compensation | 7M | 12M | 11M | 10M | 12M | 15M |
| Investing cash flow | −7M | — | — | −8M | — | — |
| Financing cash flow | −3M | — | — | 14M | — | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator